Abstract:Background Primary Sjogren's syndrome (pSS) is a chronic, systemic autoimmune disorder characterized by inflammation of exocrine glands and functional impairment of the salivary and lacrimal glands [1]. The pathogenesis of pSS is complicated with many respects remaining elusive. Interleukin-27 (IL-27) is a new member of the IL-12 cytokine family. It is largely secreted by activated antigen-presenting cells, such as macrophages and dendritic cells (DCs). IL-27 participates in multiple autoimmune diseases by regulating T lymphocyte subsets. Recent studies showed that IL-27 was involved in anti-inflammatory functions in SS [2]. However, the underlying mechanism of IL-27 in SS is still unknown. Objectives In the present study, the changes of lymphocyte subsets were studied in Il-27 knock-out and wild-type pSS models and pSS patients for the purpose to explore the specific mechanism of IL-27 in pSS and provide the basis for clinical treatment. Methods The NOD mice, Il-27 knockout (Il-27–/–) mice, Il-27 knockout mice with recombinant IL-27 treatment were studied. The saliva flow rates, weight, weight of submandibular glands and spleens were detected. Murine submandibular glands were fixed and paraffin sections were used for hematoxylin and eosin staining. The lymphocyte subsets of spleens from experimental mice and the peripheral blood from pSS patients were measured by flow-cytometric assay. Results Compared to WT NOD mice, the saliva flow rates decreased significantly, and the indexes of submandibular glands and spleens increased significantly in Il-27–/– mice (Fig 1A-E). The histological results showed that the number of lymphocytic infiltrates in submandibular glands of WT NOD was lower than Il-27–/– mice (Fig 1F). The splenic-Treg cells decreased significantly, but the levels of splenic Th17 and B cells increased significantly in Il-27–/– mice. After IL-27 treatment, the saliva flow rates, submandibular glands, Treg and Th17 cells were partially reversed in Il-27–/– mice (Fig 1G-M). Consistent with above observations, the changes of Terg and Th17 cells in pSS patients showed similar pattern. The Th2, Tfh and plasma cells increased significantly, whilst the B cells decreased significantly in pSS patients (Fig 1N-T). Compared with healthy control, the serum IL-27 decreased in pSS patients. Conclusions In general, these findings indicated that IL-27 deficiency deteriorated the disease symptoms of pSS and resulted in changes of Th17/Treg balance. In addition, pSS patients showed similar lymphocyte imbalance. Our data suggested that IL-27 might play an important role on the development and pathogenesis of pSS through regulating lymphocyte subsets, and targeting IL-27 and Th17/Treg balance may be a new direction of pSS treatment. References Xu J, Wang D, Liu D, et al. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome. Blood, 2012, 120(15): 3142–3151. Lee BH, Carcamo WC, Chiorini JA, et al. Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy. Arthritis Res Ther, 2012, 14(4): R172. Disclosure of Interest None declared

Carbon Quantum Dots As Immune Modulatory Therapy in a Sjögren's Syndrome Mouse Model.

[Effect of Prescriptions Replenishing Vital Essence, Tonifying Qi and Activating Blood on TNF-alpha, IL-1beta Expressions in Serum and Submaxillary Gland of NOD Mice with Sjogren's Syndrome].

[Effect of Yangyin Yiqi Huoxue Recipe on Immune Balance of Th1/Th2 in Serum and Submaxillary Glands of NOD Mice with Sjogren's Syndrome].

Effects of Total Glucosides of Peony on AQP-5 and Its Mrna Expression in Submandibular Glands of NOD Mice with Sjogren's Syndrome.

Effect of Nourishing Yin, Strengthening Qi and Activating Blood Decoction on Fas/FasL in Salivary Glands of NOD Mice with Sjogren's Syndrome and Their Mrna Expression

Total Glucosides of Peony Ameliorates Sjögren's Syndrome by Affecting Th1/Th2 Cytokine Balance.

Sphingosine-1-phosphate Alleviates Sjögren’s Syndrome-Like Symptoms Via Inducing Autophagy and Regulating Status of Treg Cells in NOD Mice

Qing Zao Fang (QZF) Alleviates the Inflammatory Microenvironment of the Submandibular Gland in Sjögren's Syndrome Based on the PI3K/Akt/HIF-1 α/VEGF Signaling Pathway

Umbilical Cord Mesenchymal Stem Cells Alleviate Sjögren's Syndrome and Related Pulmonary Inflammation Through Regulating Vγ4+ IL-17+ T Cells.

Altered characteristics of regulatory T cells in target tissues of Sjögren's syndrome in murine models

Effects of Multi-glycosides of Tripterygium Wilfordiion in the Treatment of Sjögren's Syndrome in the Non-obese Diabetic Mouse Model.

The Critical Biomarkers Identification of Insulin Signaling Involved in Initiating cAMP Signaling Mediated Salivary Secretion in Sjogren Syndrome: Transcriptome Sequencing in NOD Mice Model

Tetrahedral Framework Nucleic Acids Reestablish Immune Tolerance and Restore Saliva Secretion in a Sjögren’s Syndrome Mouse Model

OP0166 Il-27 Participates in Sjogren's Syndrome by Regulating Lymphocyte Subsets

Effects of Ganoderma Lucidum Spores on Sialoadenitis of Nonobese Diabetic Mice

Stem cells from exfoliated deciduous teeth alleviate hyposalivation caused by Sjögren syndrome.

Low Dose Interleukin-2 Ameliorates Sjögren’s Syndrome in a Murine Model

Low Dose Interleukin-2 Ameliorates Sjögren's Syndrome in a Murine Model

The Polysaccharide from Dendrobium officinale Can Improve Mice with Sjögren’s Syndrome by Regulating BAFF and Fas Expressions

Allogeneic Mesenchymal Stem Cell Treatment Alleviates Experimental and Clinical Sjögren Syndrome.

Effects of Adenovirus Mediated AdipoQ on Mice Submandibular Gland in Sjögren's Syndrome